论文部分内容阅读
一、ABH系统血型物质和膀胱移行上皮癌的临床、病理关系膀胱移行上皮癌占尿路恶性肿瘤发病率的首位。近十余年来,对于膀胱移行上皮癌的诊断、治疗及随访监视,都有了一定的进展,其中关于ABH系统血型物质和膀胱移行上皮癌关系的研究,尤为引人注目。1957年,Kay利用混合细胞凝集反应(MCAR)发现膀胱移行上皮癌细胞表面的ABH系统血型物质有减少或缺失现象。1972年Davidsohn利用特异的红细胞粘连试验,即SRCA方法,检测石蜡包埋的膀胱移行上皮癌的标本,注意到膀胱移行上皮癌细胞表面
First, the ABH system of blood group and bladder transitional epithelial cancer clinical, pathological relationship bladder transitional epithelial carcinoma of the urinary tract malignancy incidence of the first place. In the recent ten years, some progresses have been made in the diagnosis, treatment and follow-up surveillance of bladder transitional epithelial cancer. Among them, the research on the relationship between blood group substances in ABH and bladder transitional epithelial carcinoma is particularly noticeable. In 1957, Kay used mixed-cell agglutination (MCAR) to detect the presence or absence of ABH blood group substances on the surface of bladder transitional epithelial cancer cells. In 1972, Davidsohn used a specific erythrocyte adhesion test, the SRCA method, to detect paraffin-embedded specimens of transitional cell carcinoma of the urinary bladder, noting that the surface of bladder transitional epithelial cancer cells